On Friday for the record there was: 318,825 Shares

New Post Public Reply Private Reply Replies (0) Message Board
Sprycel
253
On Friday for the record there was:

318,825 Shares shown as BOUGHT
38,000 Shares shown as SOLD
4,500 Shares recorded as Other so take you pick

Someone was accumulating shares on Friday.

Unfortunately I can not find Thursdays log but I do know since GCAN has started trading on Sept 18, 2018 and with a float mostly below 20,000,000 there has been 116,598,836 shares traded.

My previous detailed post shows specific numbers.

The Preferred A shares are easy and the numbers have been stated on the ownership and conversion several times. To date there has been NO conversions as these shares are owned by the insiders.

I have worked on the Preferred B shares (see discussion lower in this post) and the subsequent renegotiation of the 4 notes EMET still had balances on. The 4 notes, now designated as NN1 through NN4, cannot be converted for 180 days from October 18, 2019 and are convertible at 65% of the prior 15 days lowest ending market price for conversion calculations. That puts the conversion capability into March 2020. The total of those notes is $25,586,87 and can be paid off within that 180 days time frame. The notes have a 6% per year interest and there is a payoff scale with the 180 day payoff amount being 130% of the Principal and Interest.

The actual Warrant notes were renegotiated into new conversion notes. There are 4 of them. WN1 through WN4. We can go around and around at the renegotiated pricing but I have a thought about why EMET and GCAN came to these final prices but I will save that explanation for later. The simple explanation would be if EMET bought those Warrants for $328,900 (657,800 warrants at .50 per warrant, what would they be able to sell those warrants for and to whom while common shares are much easier to sell)? These 4 notes were all issued October 18, 2019 and all are due on October 18, 2020. They are convertible at 75% of the lowest closing price within 15 days of the conversion notification. None of these notes have been converted as of this date. The entire conversion time frame from notification to the company to the T/A issuing the shares is about 10 days from start to finish. They have 2% per annum payment for interest, a $150,000.00 leak out provision per month and EMET 'can not' own more than 4.99% of the entire issued of the company. At this time that means 1,856,072 shares. My opinion is EMET is going to wait for any conversions because at a 25% discount, they would be sure to lose funds if they tried to introduce these conversion shares into the market without a huge pump or news from the company. See April 15th 2019 for an prime example of this happening. I am suspecting they will wait until the news hits so the buying pressure is reintroduced to GCAN because of the float being only 23,428,917 shares.

The T/A is open and we now have more than 1 person in contact with Luke and Pacific Transfer so any conversions will be known immediately.

Just wanted to provide some more information on the share structure of GCAN and again this is MY DD! Everyone should do their own. Thank you

Greater Cannabis Co Inc. (GCAN) Stock Research Links

GCAN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 12

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

America's Car-Mart Secures $300 Million Loan for Growth

Updated Category News Views 255

America's Car-Mart Secures Funding for Future Growth America's Car-Mart, Inc. (NASDAQ: CRMT), a leading automotive retailer, has taken a strategic step by closing a significant five-year, $300 million term loan. This loan, managed by the seasoned professionals at Silver Point Capital, L.P., aims to enhance the company’s capital structure and support its long-term growth...

Continue Reading
IASO Bio's Breakthrough Drug Application Acceptance in Singapore

Updated Category News Views 251

IASO Bio’s Major Step Forward with New Drug Application IASO Biotherapeutics, a pioneering biopharmaceutical company dedicated to the advancement of innovative cell therapies and biologics, has reached a significant milestone. The Singapore Health Sciences Authority (HSA) has officially accepted the New Drug Application (NDA) for Equecabtagene Autoleucel, known as...

Continue Reading
Creating Community Leaders: National Heritage Academies and United Way

Updated Category News Views 150

Empowering Students to Make a Difference The student-led organization is providing career opportunities while connecting with the community. National Heritage Academies® (NHA) is thrilled to celebrate its collaboration with United Way through the Student United Way program. This initiative equips high school students with essential tools and opportunities to enact...

Continue Reading
Future Growth of Augmented and Virtual Reality Technologies

Updated Category News Views 259

Exploring the Growth of Augmented Reality and Virtual Reality Market The global market for Augmented Reality (AR) and Virtual Reality (VR) is on the rise, with expectations of substantial growth over the next few years. Analysts estimate that this sector will expand by approximately USD 442.99 billion between 2024 and 2028. The compound annual growth rate (CAGR) for this...

Continue Reading
ImmVira Launches Innovative Exosome, Transforming Cosmetics

Updated Category News Views 407

ImmVira Leads the Way with Groundbreaking Exosome Technology In a remarkable advancement for the cosmetic industry, ImmVira Group has announced its innovative product, MVR-EX103, an engineered exosome specifically developed for treating superficial skin depressions. This development marks a pivotal moment, as it has successfully acquired the International Nomenclature...

Continue Reading